Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France, focused on oncology, rare diseases and neuroscience. Its current corporate logo pairs the wordmark “IPSEN” with an abstract S-shaped symbol in two shades of blue.
Design and History
The current Ipsen logo consists of a vertical dark blue S-shaped curved line that is dissected by two light blue horizontal curved lines, with a light blue dot positioned to the right of the curvature of the upper horizontal line, together with the term “IPSEN” in dark blue.[1] The same S-shaped device appears in the company’s “IPSEN INNOVATION FOR PATIENT CARE” tagline lockup, where the stylized wording appears in dark blue alongside the S-shaped design in dark blue and two smaller curved lines and a dot in light blue.[2]
The mark’s origins trace to a 2003 corporate rebranding. In May 2003, the French pharmaceutical company Beaufour Ipsen announced a change of name and logo ahead of a planned stock market listing. The Beaufour name, which belonged to the founding family from 1929, was dropped because it was considered unpronounceable by English speakers.[3] Trademark filings for “New IPSEN Logo” variants were filed in November 2003, confirming the introduction of a new visual identity at that time.[4]
Meaning and Symbolism
The visual elements are described only in formal trademark registrations, which detail the shape, arrangement and colors of the mark without attributing meaning to them.[5] Any interpretation of the symbol’s significance beyond its registered description would be speculative.
Typography and Design
The Ipsen wordmark is rendered in dark blue lettering, as documented in trademark filings.[1] The company’s colors are formally claimed in its trademark registrations as dark blue (Pantone 281C) and light blue (Pantone 7461C).[5] No official source identifies the specific typeface used in the wordmark.
Logo Index is an independent educational archive covering logos, visual identities and graphic design history. All trademarks and brand assets remain the property of their respective owners.
